Amyloidosis: all 495 studies
Page 1 of 5. Open to participants first (135), then studies with results posted, then the rest; newest registration first within each.
- Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain AmyloidosisNot yet recruitingNCT07874334Phase 1
- Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) AmyloidosisNot yet recruitingNCT07793422Phase 3
- A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL AmyloidosisNot yet recruitingNCT07765524Phase 1/2
- Non-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With Higher-Grade Aortic Valve Stenosis - Evaluation Using Echocardiography, Computed Tomography, Tc99-SPECT/CT and Cardiac Magnetic Resonance Imaging (CMR)RecruitingNCT07752732
- Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion SystemNot yet recruitingNCT07721350Not applicable
- A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of NXC-201 Compared With Daratumumab With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) in Newly Diagnosed Systemic AL AmyloidosisNot yet recruitingNCT07709715Phase 3
- Cardiac Magnetic Resonance and Echocardiography Study With AcoramidisRecruitingNCT07695701Phase 4
- PET/CT Imaging in Carriers of TTR MutationsNot yet recruitingNCT07591038
- Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial FibrillationNot yet recruitingNCT07567508Not applicable
- [64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid CardiomyopathyRecruitingNCT07560306Phase 3
- PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 LevelsNot yet recruitingNCT07538518
- Impact of a Cardiac Rehabilitation Program on Patients With Cardiac AmyloidosisRecruitingNCT07494942Not applicable
- AGE and CALLY Index in Familial Mediterranean FeverNot yet recruitingNCT07439341
- A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)RecruitingNCT07388602Phase 3
- DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World SettingRecruitingNCT07358078
- Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisRecruitingNCT07301892
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL AmyloidosisRecruitingNCT07250269Phase 1
- [18F]FT8 PET Imaging in Immunoglobulin Light Chain AmyloidosisRecruitingNCT07232459
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) AmyloidosisRecruitingNCT07224672Phase 2
- TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With PolyneuropathyRecruitingNCT07223203Phase 3
- A Study Of MCG In Cardiac AmyloidosisRecruitingNCT07218705
- A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance ElastographyRecruitingNCT07216469
- A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain AmyloidosisRecruitingNCT07215494Not applicable
- Comprehensive Program for Hereditary Transthyretin AmyloidosisRecruitingNCT07213297
- Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker StudyRecruitingNCT07196839
- BE.Amycon Biobank & Data Registry UZ LeuvenRecruitingNCT07172243
- Pan-Amyloid PET/CT in Various Amyloid-Related DiseaseRecruitingNCT07130565
- To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)Not yet recruitingNCT07116473Phase 3
- A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.RecruitingNCT07081646Phase 1/2
- TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyRecruitingNCT07052903Phase 3
- Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadRecruitingNCT06974877Phase 1
- Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain AmyloidosisRecruitingNCT06971380Phase 2
- Teclistamab in Previously Treated AL AmyloidosisRecruitingNCT06935162Phase 2
- 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel SyndromeEnrolling by invitationNCT06907849Phase 2
- Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal MedicineRecruitingNCT06907836
- An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With CardiomyopathyRecruitingNCT06907186Not applicable
- International Cardiac Amyloidosis RegistryRecruitingNCT06894290
- Essen Amyloidosis RegistryRecruitingNCT06887283
- Observational Epidemiological Study of Patients Suffering From Systemic AmyloidosisRecruitingNCT06866912
- Phenotypic and Molecular Characterisation of Cerebral Amyloid AngiopathyRecruitingNCT06864000
- A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.RecruitingNCT06836011
- Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac TransplantationRecruitingNCT06813443
- The Impact of Systemic Light Chain Amyloidosis on EyesRecruitingNCT06803082
- MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac AmyloidosisRecruitingNCT06799273
- PL_GNT01_ISR_Grant 53234273Enrolling by invitationNCT06714019
- Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionNot yet recruitingNCT06712030Phase 3
- Prospective Study of Teclistamab in the Treatment of Systemic AL AmyloidosisRecruitingNCT06699394Not applicable
- A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With CardiomyopathyEnrolling by invitationNCT06679946Phase 3
- A Phase 3 Study of NTLA-2001 in ATTRv-PNRecruitingNCT06672237Phase 3
- Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathyRecruitingNCT06634108Phase 1/2
- Institutional Registry of Rare DiseasesRecruitingNCT06573723
- Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantRecruitingNCT06563895Phase 3
- A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)RecruitingNCT06539208Phase 1/2
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesRecruitingNCT06539169
- Prevalence of Amyloidosis in Trauma PatientsRecruitingNCT06527521
- EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)Not yet recruitingNCT06499064Not applicable
- Non-interventional Study of Patients With Transthyretin (ATTR) AmyloidosisRecruitingNCT06465810
- Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm StudyRecruitingNCT06455748Not applicable
- Exercise Training and Rehabilitation In Cardiac AmyloidosisEnrolling by invitationNCT06412432Not applicable
- Daratumumab for Patients With Light Chain AmyloidosisRecruitingNCT06376214Not applicable
- Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)RecruitingNCT06367842
- New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin AmyloidosisRecruitingNCT06345235
- Bortezomib, Pomalidomide, Dexamethasone for Systemic AL AmyloidosisRecruitingNCT06342466Phase 2
- Thailand ATTR-CM RegistryRecruitingNCT06338696
- Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac AmyloidosisRecruitingNCT06328075
- NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on TafamidisRecruitingNCT06251778
- Affection of Renal and Urinary System in IBD PatientsNot yet recruitingNCT06249243
- Amyloidosis Incidence in High-Risk Cardiac Device PatientsRecruitingNCT06186167
- Validation of Different Diagnostic Modalities in the Detection of Cardiac Amyloidosis Among Patients With "Red Flags"Not yet recruitingNCT06175858Not applicable
- A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) InfusionRecruitingNCT06158854Phase 1/2
- Cardiac Amyloidosis Registry of University Hospital LeipzigRecruitingNCT06129656
- Aortic Stenosis and Cardiac AmyloidosisRecruitingNCT06129331
- MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)RecruitingNCT06128629Phase 3
- Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis SurgeryRecruitingNCT06101108
- Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis CardiomyopathyRecruitingNCT06082050Early Phase 1
- Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study)RecruitingNCT06066632
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- 18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL AmyloidosisRecruitingNCT06048601Not applicable
- Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVRNot yet recruitingNCT06015997
- A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic AmyloidosisRecruitingNCT05951816Phase 1
- Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.RecruitingNCT05950867Not applicable
- RWE-based Treatment Patterns and Outcomes in CIDPNot yet recruitingNCT05940922
- Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start TreatmentNot yet recruitingNCT05938218Not applicable
- Exploring Biomarkers in Hereditary Transthyretin AmyloidosisRecruitingNCT05929209Not applicable
- Better Classification of Respiratory AmyloidosisNot yet recruitingNCT05862961
- The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.RecruitingNCT05814380
- Exercise Training in Transthyretin Cardiac AmyloidosisRecruitingNCT05797857Not applicable
- Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL AmyloidosisNot yet recruitingNCT05776940Phase 3
- Quantitative-imaging in Cardiac Transthyretin AmyloidosisRecruitingNCT05776212
- Prognostic Value of Echocardiographic Parameters Based on Machine Learning ApproachRecruitingNCT05772091
- Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic AmyloidosisRecruitingNCT05758493Phase 2
- Dietary Reporting In The AmyloidosesRecruitingNCT05738005Not applicable
- Prognosis of Cerebral Small Vessel DiseaseRecruitingNCT05734378
- An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)Enrolling by invitationNCT05667493Phase 3
- A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisRecruitingNCT05652335Phase 1
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
- A Multi-center Cardiac PYP Scan Registry in TaiwanRecruitingNCT05593679
- Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEFRecruitingNCT05577819Not applicable
- Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme RegistryRecruitingNCT05556928